A solid-phase receptor binding assay for 125I-hCG

M. Bortolussi, O. Selmin, A. Colombatti

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


A solid-phase radioligand-receptor assay (RRA) to measure the binding of 125I-labelled human chorionic gonadotropin (125I-hCG) to target cell membranes has been developed. The binding of 125I-hCG to membranes immobilized on the wells of microtitration plates reached a maximum at about 3 hours at 37°C, was saturable, displayed a high affinity (Ka = 2.4 × 109M−1) and was specifically inhibited by unlabelled hCG. In comparison with RRAs carried out with membranes in suspension, the solid-phase RRA is significantly simpler and much faster to perform as it avoids centrifugation or filtration procedures. The solid-phase RRA was adapted profitably to process large numbers of samples at the same time. It proved particularly useful as a screening assay to detect anti-hCG monoclonal antibodies with high inhibitory activity for binding of 125I-hCG to its receptors.

Original languageEnglish (US)
Pages (from-to)219-235
Number of pages17
JournalJournal of Immunoassay
Issue number2-3
StatePublished - Jun 1 1987

ASJC Scopus subject areas

  • Immunology
  • Pharmacology


Dive into the research topics of 'A solid-phase receptor binding assay for 125I-hCG'. Together they form a unique fingerprint.

Cite this